A Phase 3, Multicenter, Randomized, Double-blind, Parallel-group, Safety and Efficacy Study of Linaclotide versus Placebo in Pediatric Subjects, Ages 2 to 5 Years, with Functional Constipation (FC) with a 24-week Open-label Treatment Extension
CompletedCTIS2022-501946-31-00
Abbvie Deutschland GmbH & Co. KGFunctional Constipation
Start: 2024-02-29End: 2025-06-30Target: 14Updated: 2025-05-19